Oxtoby Andrew 4
4 · CHINOOK THERAPEUTICS, INC. · Filed Mar 2, 2023
Insider Transaction Report
Form 4
Oxtoby Andrew
Chief Commercial Officer
Transactions
- Award
Restricted Stock (RSU)(Common Stock)
2023-02-28+40,000→ 40,000 total→ Common Stock (40,000 underlying) - Award
Stock Option (right to buy)
2023-02-28+160,000→ 160,000 totalExercise: $21.82Exp: 2033-02-27→ Common Stock (160,000 underlying)
Footnotes (3)
- [F1]The stock option vests as to 25% of the total shares on February 28, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on February 28, 2024, until fully vested subject to the Reporting Person's provision of service to the Issuer on each vesting date.